Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Invertebrate and fungal model organisms: emerging platforms for drug discovery.

Stilwell GE, Westlund B.

Expert Opin Drug Discov. 2008 Dec;3(12):1383-95. doi: 10.1517/17460440802528139.

PMID:
23506104
2.

Chemical genomics and emerging DNA technologies in the identification of drug mechanisms and drug targets.

Olsen LC, Færgeman NJ.

Curr Top Med Chem. 2012;12(12):1331-45. Review.

PMID:
22690680
3.

Invertebrate disease models in neurotherapeutic discovery.

Westlund B, Stilwell G, Sluder A.

Curr Opin Drug Discov Devel. 2004 Mar;7(2):169-78. Review.

PMID:
15603250
4.

Invertebrate animal models of diseases as screening tools in drug discovery.

Ségalat L.

ACS Chem Biol. 2007 Apr 24;2(4):231-6. Review.

PMID:
17455900
5.

Drug Discovery in Fish, Flies, and Worms.

Strange K.

ILAR J. 2016 Dec;57(2):133-143. doi: 10.1093/ilar/ilw034. Review.

6.

Microfluidic tools for developmental studies of small model organisms--nematodes, fruit flies, and zebrafish.

Hwang H, Lu H.

Biotechnol J. 2013 Feb;8(2):192-205. doi: 10.1002/biot.201200129. Epub 2012 Nov 19. Review.

7.

Caenorhabditis elegans: a versatile platform for drug discovery.

Artal-Sanz M, de Jong L, Tavernarakis N.

Biotechnol J. 2006 Dec;1(12):1405-18. Review.

PMID:
17109493
8.
9.
10.

Drosophila and Caenorhabditis elegans as Discovery Platforms for Genes Involved in Human Alcohol Use Disorder.

Grotewiel M, Bettinger JC.

Alcohol Clin Exp Res. 2015 Aug;39(8):1292-311. doi: 10.1111/acer.12785. Epub 2015 Jul 14. Review.

11.

Drosophila melanogaster neurobiology, neuropharmacology, and how the fly can inform central nervous system drug discovery.

Nichols CD.

Pharmacol Ther. 2006 Dec;112(3):677-700. Epub 2006 Aug 28. Review.

PMID:
16935347
12.

Drosophila melanogaster as a model host for the study of microbial pathogenicity and the discovery of novel antimicrobial compounds.

Chamilos G, Samonis G, Kontoyiannis DP.

Curr Pharm Des. 2011;17(13):1246-53. Review.

PMID:
21470115
13.

Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery.

Pandey UB, Nichols CD.

Pharmacol Rev. 2011 Jun;63(2):411-36. doi: 10.1124/pr.110.003293. Epub 2011 Mar 17. Review.

14.

Novel trends in high-throughput screening.

Mayr LM, Bojanic D.

Curr Opin Pharmacol. 2009 Oct;9(5):580-8. doi: 10.1016/j.coph.2009.08.004. Epub 2009 Sep 21. Review.

PMID:
19775937
15.

Neurodegenerative diseases: Lessons from genome-wide screens in small model organisms.

van Ham TJ, Breitling R, Swertz MA, Nollen EA.

EMBO Mol Med. 2009 Nov;1(8-9):360-70. doi: 10.1002/emmm.200900051. Review.

16.

The retinoblastoma tumour suppressor in model organisms--new insights from flies and worms.

Korenjak M, Brehm A.

Curr Mol Med. 2006 Nov;6(7):705-11. Review.

PMID:
17100596
17.

Fruitful research: drug target discovery for neurodegenerative diseases in Drosophila.

Konsolaki M.

Expert Opin Drug Discov. 2013 Dec;8(12):1503-13. doi: 10.1517/17460441.2013.849691. Epub 2013 Oct 23. Review.

PMID:
24151920
18.

Cell-cell adhesion via the ECM: integrin genetics in fly and worm.

Brown NH.

Matrix Biol. 2000 Jul;19(3):191-201. Review.

PMID:
10936444
19.

[Caenorhabditis elegans: a powerful tool for drug discovery].

Jia XH, Cao C.

Yao Xue Xue Bao. 2009 Jul;44(7):687-94. Review. Chinese.

PMID:
19806904
20.

Big ideas for small brains: what can psychiatry learn from worms, flies, bees and fish?

Burne T, Scott E, van Swinderen B, Hilliard M, Reinhard J, Claudianos C, Eyles D, McGrath J.

Mol Psychiatry. 2011 Jan;16(1):7-16. doi: 10.1038/mp.2010.35. Epub 2010 Mar 30. Review.

PMID:
20351718

Supplemental Content

Support Center